Barcelona, Spain

Julio Campón Pardo

This inventor holds 1 USPTO granted patent. Top assignee: Esteve Química, S.a.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Julio Campón Pardo. Retrieved from https://idiyas.com/inventor/julio-campandoacuten-pardo

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Julio Campón Pardo: Innovator in Pharmaceutical Chemistry

Introduction

Julio Campón Pardo is a notable inventor based in Barcelona, Spain. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. His work has led to the development of innovative processes that enhance the efficacy of medications.

Latest Patents

Julio holds a patent for an "Intermediate for the synthesis of amlodipine, a process for the preparation thereof and corresponding use." This patent reflects his expertise in creating intermediates that are crucial for the production of effective pharmaceutical agents.

Career Highlights

Julio is currently employed at Esteve Química, S.A., a company known for its commitment to pharmaceutical innovation. His role at Esteve Química allows him to apply his knowledge and skills in a collaborative environment focused on advancing healthcare solutions.

Collaborations

Throughout his career, Julio has worked alongside talented colleagues, including Laura Coppi and Yolanda Gasanz Guillén. These collaborations have fostered a dynamic exchange of ideas and have contributed to the success of various projects within the company.

Conclusion

Julio Campón Pardo exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborative efforts continue to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…